Aktia Bank Plc
Aktia Bank Plc
Stock Exchange Release
4 March 2021 at 4.15 p.m.
Aktia Bank Plc: Managers’ Transactions – Carola Nilsson
Person subject to the notification requirement
Name: Nilsson, Carola
Position: Other senior manager
Issuer: Aktia Bank plc
LEI: 743700GC62JLHFBUND16
Notification type: INITIAL NOTIFICATION
Reference number: 743700GC62JLHFBUND16_20210303101625_56
____________________________________________
Transaction date: 2021-03-02
Venue not applicable
Instrument type: SHARE
ISIN: FI4000058870
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 769 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 769 Volume weighted average price: 0.00 EUR
Aktia Bank Plc
Further information:
Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587
Distribution:
Nasdaq Helsinki Ltd
Mass media
www.aktia.com
Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsinki, Turku, Tampere, Vaasa and Oulu regions. Our award-winning asset management business sells investment funds internationally. We employ approximately 830 people around Finland. Aktia's assets under management (AuM) on 31 December 2020 amounted to EUR 10.4 billion, and the balance sheet total was EUR 10.6 billion. Aktia's shares are listed on Nasdaq Helsinki Ltd (AKTIA). aktia.com.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bombardier Inc.13.10.2025 22:02:56 CEST | Press release
Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95
Zymeworks Inc.13.10.2025 22:00:00 CEST | Press release
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
Bombardier Inc.13.10.2025 21:00:00 CEST | Press release
Bombardier Unveils Comlux as Global 8000 Aircraft Customer, Delivery Confirmed for 2026
Cosmos Health Inc.13.10.2025 20:05:46 CEST | Press release
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
Sequana Medical NV13.10.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholder
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom